Cancer Epidemiology Biomarkers & Prevention

Papers
(The H4-Index of Cancer Epidemiology Biomarkers & Prevention is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Adolescent Physical Activity and Breast Cancer Risk in Young Women: Findings From the ProF-SC Study217
Association Between Clinical, Demographic Factors, and Substance Use Among Young Adult Survivors of Childhood Cancer102
Racial Disparities in Prostate Cancer Mortality Rates Partially Explained By Differences in Dietary and Lifestyle Factors62
Abstract C082: A case of intracranial myeloid sarcoma discovered after a subdural hematoma55
Abstract B090: Understanding the impact of health literacy on the perceptions of health misinformation on social media in young adults49
Abstract B033: At-risk alcohol intake and clinically meaningful weight loss among overweight/obese Latinos in a nutrition education program46
Abstract B121: Developing organoid model to study drug-resistant breast cancer cells44
Abstract A027: Acceptability of a culturally adapted mindfulness-based intervention for Hispanic cancer patients and their family caregivers44
Abstract B125: Risk of late effects and acute care utilization among childhood, adolescent, and young adult cancer survivors with Medicaid coverage43
Abstract C148: A literature review on patient intervention strategies to improve cancer screening adherence40
Abstract B160: Racial disparities in CAR T-cell therapy utilization and outcomes among patients with diffuse large B-cell lymphoma: A matched cohort study39
Abstract A164: Social vulnerability index and climate extreme events impact on the excess mortality among Puerto Rican cancer patients38
Abstract B001: Validating tumor-infiltrating lymphocyte classification in primary cutaneous melanoma using cytokine immune scores: Addressingbbiomarker disparities in underserved populations38
Abstract A132: Microbiome-related gastrointestinal cancers and survival: Racial and geographic inequities from a population-based analysis37
Abstract A015: Social vulnerability and breast cancer incidence in the United States: A county-level bivariate analysis34
Abstract C146: Cervical cancer screening guideline concordance among sexual minority females in the 2019, 2021, and 2023 National Health Interview Survey (NHIS)33
Abstract B053: A multi-method, collaborative approach in evaluating the experiences and identifying equity-related barriers for Black individuals in follow up care for radical prostatectomy and second32
Abstract 9: Immunohistochemical Profiling of the Tumor Microenvironment in Ethiopian Breast Cancer Tissue: Insights into Pathology and Subtypes31
Abstract 52: Barriers to Breast Cancer Diagnosis in Tanzania: Patient Perspectives and Recommendations for Improvement31
Abstract 34: Introducing a Novel Financial Navigation Program for Cancer Patients in Nigeria: A Pilot Survey of Stakeholders31
Can We Interpret Analyses of Etiologic Heterogeneity When Molecular Markers Are Used to Classify Tumors?30
Molecular Subtypes of High-Grade Serous Ovarian Cancer across Racial Groups and Gene Expression Platforms30
Association between Dietary Anthocyanidins and Biliary Cancer Risk in 98,458 Participants: Results from a Prospective Study29
Prospective and Cross-sectional Associations of the Rectal Tissue Microbiome with Colorectal Adenoma Recurrence28
Association Study between Polymorphisms in DNA Methylation–Related Genes and Testicular Germ Cell Tumor Risk28
Association of Cancer History with COVID-19 Risk and Outcomes among Older Postmenopausal Women: Results from the Women’s Health Initiative27
A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa27
0.13096189498901